Citigroup Inc Sage Therapeutics, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 69,106 shares of SAGE stock, worth $395,977. This represents 0.0% of its overall portfolio holdings.

Number of Shares

69,106

Previous 42,898 61.09%

Holding current value

$395,977

Previous $465,000 7.1%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$7.02 - $13.08 $183,980 - $342,800	26,208 Added 61.09%	69,106 $498,000
Q2 2024 Aug 12, 2024	SELL	$10.58 - $17.9 $3.11 Million - $5.25 Million	-293,575 Reduced 87.25%	42,898 $465,000
Q1 2024 May 10, 2024	BUY	$18.62 - $26.95 $3.95 Million - $5.72 Million	212,110 Added 170.56%	336,473 $6.31 Million
Q4 2023 Feb 09, 2024	SELL	$17.1 - $22.26 $892,791 - $1.16 Million	-52,210 Reduced 29.57%	124,363 $2.69 Million
Q3 2023 Nov 09, 2023	BUY	$16.75 - $48.98 $1.82 Million - $5.33 Million	108,814 Added 160.59%	176,573 $3.63 Million
Q2 2023 Aug 10, 2023	SELL	$40.65 - $59.54 $2.69 Million - $3.94 Million	-66,103 Reduced 49.38%	67,759 $3.19 Million
Q1 2023 May 11, 2023	BUY	$37.27 - $46.57 $2.25 Million - $2.81 Million	60,361 Added 82.12%	133,862 $5.62 Million
Q4 2022 Feb 09, 2023	SELL	$32.2 - $43.61 $2.54 Million - $3.43 Million	-78,756 Reduced 51.73%	73,501 $2.8 Million
Q3 2022 Nov 10, 2022	BUY	$32.28 - $43.27 $1.64 Million - $2.2 Million	50,926 Added 50.26%	152,257 $5.96 Million
Q2 2022 Aug 10, 2022	BUY	$27.52 - $37.99 $930,891 - $1.29 Million	33,826 Added 50.11%	101,331 $3.27 Million
Q1 2022 May 12, 2022	SELL	$30.71 - $45.71 $3.06 Million - $4.55 Million	-99,629 Reduced 59.61%	67,505 $2.23 Million
Q4 2021 Feb 10, 2022	BUY	$37.06 - $47.11 $4.24 Million - $5.39 Million	114,318 Added 216.45%	167,134 $7.11 Million
Q3 2021 Nov 10, 2021	BUY	$40.26 - $57.37 $2.13 Million - $3.03 Million	52,816 New	52,816 $2.34 Million

Others Institutions Holding SAGE

# of Institutions

218

Shares Held

46.4M

Call Options Held

847K

Put Options Held

188K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $340M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account